The independent source for health policy research, polling, and news.
2,301-2,320 of 112,996 results
The lawsuit addresses the practice of dropping family caregiver application appeals once a veteran dies from military-related illnesses. The caregivers want to receive compensation for the time they provided care. Plus: Medicaid cuts, insurance denials, and more.
This list price for the highest dose of Mounjaro, for example, would go from roughly $165 to $447 in the United Kingdom. The drugmaker says this in effect would then "make them lower in the U.S.” Plus, a look at how President Trump's tariffs would affect drug manufacturers that rely on Ireland.
The moral and religious carve-outs to contraceptive coverage under the Affordable Care Act were deemed arbitrary, capricious, and an overreach of the administration's authority, The Hill reports. Separately, scientists want to study mifepristone's potential for breast cancer prevention but can't.
In an effort to satisfy the demands of anti-vaccine activists, HHS announced Thursday that the Task Force on Safer Childhood Vaccines will be restored. Experts are worried this move will undermine confidence in childhood vaccines.
Today's early morning highlights from the major news organizations.
The rare and mostly fatal amebic infection happens when a parasite enters the body of someone swimming in warm water. Also, the stratus covid variant is surging in 12 states.
Each week, KFF Health News compiles a selection of the latest health research and news.
Editorial writers tackle these public health topics.
Scientists are warning people that it isn't just covid vaccines that will be affected. In other vaccine news: RFK Jr.'s criticisms of the hepatitis B vaccine; updates on Vinay Prasad; and successful results from the HPV vaccine rollout, and more.
As of last week, Illinois joins Nevada and Utah in no longer allowing chatbots or AI to be used by therapists in any capacity other than administrative. The ban also extends to companies that offer AI-powered therapy services without licensed therapists' involvement. More news is from Arkansas, New York, Arizona, Maryland, Minnesota, Texas, Florida, and North Carolina.
The study also noted a 15% drop in substance misuse and showed benefit for patients who were taking stimulant medications rather than nonstimulants. Plus: developing new painkillers; how semaglutide affects muscle strength; and more.
The man is accused of making repeated threatening calls to Brian Thompson's family member. He is due in court today. Other news is about a Mission Health settlement, reduced workforces at Providence and CentraCare, and Oracle's EHR platform.
Mars Wrigley Inc. made the announcement without fanfare on its website many weeks ago — two days after meeting with FDA Chief Marty Makary, Bloomberg reported. The company will unveil "options made without FD&C colors" next year.
A federal appeals panel voted 2-to-1 against a group of international aid groups, ruling they did not have the legal standing to bring a lawsuit. Meanwhile, the Trump administration has ordered a six-month stockpile of advanced pharmaceutical ingredients; drug companies have formed a group to present research on the negative effects of Medicare drug price negotiations; and more.
Today's early morning highlights from the major news organizations.
Gallup's annual Consumption Habits survey found only 54% of U.S. adults drank alcohol in 2025. Separately, research shows that autism is being diagnosed earlier in young children, but girls still wait longer than boys. Also in the news: dementia, cancer, and warnings about the herbal tonic "Feel Free."
The State Board of Education on Tuesday approved a plan to close the schools, citing issues of declining enrollment, staffing struggles, and deferred maintenance. Other states making news: New York, Wyoming, Florida, California, and Texas.
Multiple pharmaceutical firms are researching whether their blockbuster weight loss drugs can also help treat early Alzheimer's. Plus: The FDA has approved the first treatment for non-cystic fibrosis bronchiectasis in people 12 and older.
Researchers found AI tools helped professionals to spot precancerous colon growths more easily, but when the AI tool was removed, their abilities to find tumors fell about 20% compared with rates before they used AI. Meanwhile, a report says AI adoption is racing far ahead of health system governance.
Opinion writers discuss these public health issues.
© 2026 KFF